CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to GILD

Sacituzumab Govitecan

Phase 2
Gilead Sciences, Inc. (GILD)

Phase 2

Development Phase

2

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q2 '27
GILDPhase 2

Sacituzumab Govitecan Phase 2 Est. Readout

Sacituzumab Govitecan
Q2 2027~Q
CT.gov
00%
Dec '26
GILDPhase 2

Sacituzumab govitecan Phase 2 Est. Readout

Sacituzumab Govitecan
Dec 2026~
CT.gov
00%
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.